Dare Bioscience, Inc. — Form 8-K
Filed July 13, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 15/100
What the filing says
Dare Bioscience (market cap $21.3M) filed an 8-K on July 13, 2026, under Items 7.01 and 9.01, disclosing regulated FD information and exhibits. The filing contains 39 graphic files but the actual text content of the disclosure document is not provided in this filing index — only a table of contents listing documents is visible. Specific business details, dollar amounts, counterparties, or material events cannot be determined from this index.
Why this rating
Filing structure and graphics alone reveal no business substance. Without readable disclosure content, no material event can be assessed relative to the $21.3M company size.
Extracted items
- 7.01 Reg FD disclosure
- 9.01 exhibits
See more from July 13, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.